GMED: Financial results

Item 2.02. Results of Operations and Financial Condition. On August 6, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting, among other things, its sales and operating results for the three and six month period ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibit attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated August 6, 2026 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLOBUS MEDICAL, INC. (Registrant) Dated: August 6, 2026 /s/ KYLE R. KLINE Kyle R. Kline Chief Financial Officer (Principal Financial Officer) Senior Vice President